184 related articles for article (PubMed ID: 31869001)
1. Role of NT-proBNP in the prediction of moderate to severe Bronchopulmonary Dysplasia in preterm infants.
Khan S; Concina VA; Schneider D; Westgate P; Arriagada S; Bada H
Pediatr Pulmonol; 2020 Feb; 55(2):376-382. PubMed ID: 31869001
[TBL] [Abstract][Full Text] [Related]
2. N-terminal-probrain natriuretic peptide as a biomarker of moderate to severe bronchopulmonary dysplasia in preterm infants: A prospective observational study.
Rodríguez-Blanco S; Oulego-Erroz I; Alonso-Quintela P; Terroba-Seara S; Jiménez-González A; Palau-Benavides M
Pediatr Pulmonol; 2018 Aug; 53(8):1073-1081. PubMed ID: 29790673
[TBL] [Abstract][Full Text] [Related]
3. N-Terminal Pro-B Type Natriuretic Peptide as a Marker of Bronchopulmonary Dysplasia or Death in Very Preterm Neonates: A Cohort Study.
Sellmer A; Hjortdal VE; Bjerre JV; Schmidt MR; McNamara PJ; Bech BH; Henriksen TB
PLoS One; 2015; 10(10):e0140079. PubMed ID: 26452045
[TBL] [Abstract][Full Text] [Related]
4. Diseases associated with prematurity in correlation with N-terminal pro-brain natriuretic peptide levels during the early postnatal life.
Fritz AS; Keller T; Kribs A; Hünseler C
Eur J Pediatr; 2023 Jul; 182(7):3075-3082. PubMed ID: 37072630
[TBL] [Abstract][Full Text] [Related]
5. Natriuretic peptides in bronchopulmonary dysplasia: a systematic review.
Xiong T; Kulkarni M; Gokulakrishnan G; Shivanna B; Pammi M
J Perinatol; 2020 Apr; 40(4):607-615. PubMed ID: 31925319
[TBL] [Abstract][Full Text] [Related]
6. B-type natriuretic peptide levels in preterm neonates with bronchopulmonary dysplasia: a marker of severity?
Kalra VK; Aggarwal S; Arora P; Natarajan G
Pediatr Pulmonol; 2014 Nov; 49(11):1106-11. PubMed ID: 24214578
[TBL] [Abstract][Full Text] [Related]
7. Patent ductus arteriosus, systemic NT-proBNP concentrations and development of bronchopulmonary dysplasia in very preterm infants: retrospective data analysis from a randomized controlled trial.
Potsiurko S; Dobryanskyy D; Sekretar L
BMC Pediatr; 2021 Jun; 21(1):286. PubMed ID: 34147090
[TBL] [Abstract][Full Text] [Related]
8. Factors affecting N-terminal pro-B-type natriuretic peptide levels in preterm infants and use in determination of haemodynamic significance of patent ductus arteriosus.
Harris SL; More K; Dixon B; Troughton R; Pemberton C; Horwood J; Ellis N; Austin N
Eur J Pediatr; 2018 Apr; 177(4):521-532. PubMed ID: 29352349
[TBL] [Abstract][Full Text] [Related]
9. NTproBNP is a useful early biomarker of bronchopulmonary dysplasia in very low birth weight infants.
Méndez-Abad P; Zafra-Rodríguez P; Lubián-López S; Benavente-Fernández I
Eur J Pediatr; 2019 May; 178(5):755-761. PubMed ID: 30820654
[TBL] [Abstract][Full Text] [Related]
10. N-Terminal Pro-B-Type Natriuretic Peptide as a Biomarker of Bronchopulmonary Dysplasia or Death in Preterm Infants: A Retrospective Cohort Analysis.
Zhou L; Xiang X; Wang L; Chen X; Zhu J; Xia H
Front Pediatr; 2019; 7():166. PubMed ID: 31134166
[No Abstract] [Full Text] [Related]
11. Brain Natriuretic Propeptide as an Early Marker of Bronchopulmonary Dysplasia or Death in the Preterm Newborn.
Montaner A; Pinillos R; Galve Z; Boix H; de la Cuesta CR; Jimenez L; Samper P; Rite S
Klin Padiatr; 2017 Jul; 229(4):223-228. PubMed ID: 28718187
[No Abstract] [Full Text] [Related]
12. Biochemical Screening for Pulmonary Hypertension in Preterm Infants with Bronchopulmonary Dysplasia.
Montgomery AM; Bazzy-Asaad A; Asnes JD; Bizzarro MJ; Ehrenkranz RA; Weismann CG
Neonatology; 2016; 109(3):190-4. PubMed ID: 26780635
[TBL] [Abstract][Full Text] [Related]
13. Lung ultrasound score has better diagnostic ability than NT-proBNP to predict moderate-severe bronchopulmonary dysplasia.
Alonso-Ojembarrena A; Méndez-Abad P; Alonso-Quintela P; Zafra-Rodríguez P; Oulego-Erroz I; Lubián-López SP
Eur J Pediatr; 2022 Aug; 181(8):3013-3021. PubMed ID: 35648231
[TBL] [Abstract][Full Text] [Related]
14. Development of a Nomogram for Moderate-to-Severe Bronchopulmonary Dysplasia or Death: Role of N-Terminal Pro-brain Natriuretic Peptide as a Biomarker.
Song M; Lei M; Luo C; Shi Z; Cheng X; Ding W; Cao W; Zhang J; Ge J; Wang M; Xia P; Mao F; Wang L; Zhang Q
Front Pediatr; 2021; 9():727362. PubMed ID: 34497786
[No Abstract] [Full Text] [Related]
15. N-terminal pro-B-type natriuretic peptide as a marker of bronchopulmonary dysplasia in premature infants.
Joseph L; Nir A; Hammerman C; Goldberg S; Ben Shalom E; Picard E
Am J Perinatol; 2010 May; 27(5):381-6. PubMed ID: 20013606
[TBL] [Abstract][Full Text] [Related]
16. [Value of amino-terminal pro-brain natriuretic peptide as a predictive marker of symptomatic patent ductus arteriosus in preterm infants].
Lu KS; Guo XL; Lv JF; Huang SL; Yang CH; Zou ZH; Chen ZJ; Lai CH; Yang BY
Zhongguo Dang Dai Er Ke Za Zhi; 2015 Nov; 17(11):1160-4. PubMed ID: 26575871
[TBL] [Abstract][Full Text] [Related]
17. Serial N-terminal pro-brain natriuretic peptide measurement as a predictor of significant patent ductus arteriosus in preterm infants beyond the first week of life.
Letshwiti JB; Sirc J; O'Kelly R; Miletin J
Eur J Pediatr; 2014 Nov; 173(11):1491-6. PubMed ID: 24898778
[TBL] [Abstract][Full Text] [Related]
18. N-terminal-pro-brain natriuretic peptide: a guide for early targeted indomethacin therapy for patent ductus arteriosus in preterm Infants.
Nuntnarumit P; Chongkongkiat P; Khositseth A
Acta Paediatr; 2011 Sep; 100(9):1217-21. PubMed ID: 21457304
[TBL] [Abstract][Full Text] [Related]
19. NTproBNP as a surrogate biomarker for early screening of pulmonary hypertension in preterm infants with bronchopulmonary dysplasia.
Dasgupta S; Aly AM; Malloy MH; Okorodudu AO; Jain SK
J Perinatol; 2018 Sep; 38(9):1252-1257. PubMed ID: 29977013
[TBL] [Abstract][Full Text] [Related]
20. Reference values for N-terminal Pro-brain natriuretic peptide in premature infants during their first weeks of life.
Fritz AS; Keller T; Kribs A; Hünseler C
Eur J Pediatr; 2021 Apr; 180(4):1193-1201. PubMed ID: 33141298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
